The trial, carried out by pulmonologist Sara Ghandehari of the Cedars-Sinai hospital in Los Angeles, recruited 40 male patients hospitalized with COVID-19.
“As an ICU doctor, I was struck by the gender disparity among COVID-19 patients who were very sick, remained in the hospital, and needed ventilators,” she emphasized.
“One group acted as a control sample, for comparison, and received only the standard medical care given at that time for the disease. The experimental group, meanwhile, also received 100-milligram injections of progesterone twice daily for five days during the time they were hospitalized. All the patients were assessed by the team daily for either 15 days or until they were discharged from hospital,” a summary notes.
h/t Tallahassee on Gab